Tonix Pharmaceuticals Holding Corp. (TNXP) Balance sheet
Market cap
$122.55M
P/E ratio
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | - | - | 19 | 19 | 26 | 11 | 77 | 179 | 120 | 26 | 100 |
| Marketable securities, current | - | - | - | 7 | - | - | - | - | - | - | - |
| Total cash & short-term investments | - | - | 19 | 26 | 26 | 11 | 77 | 179 | 120 | 26 | 100 |
| Accounts receivable, net | - | - | - | - | - | - | - | - | - | - | 4 |
| Inventories | - | - | - | - | - | - | - | - | - | 14 | 8 |
| Total current assets | 9 | 39 | 46 | 27 | 26 | 14 | 88 | 189 | 131 | 48 | 119 |
| Property, plant and equipment, net | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 51 | 94 | 94 | 42 |
| Total non-current assets | 0 | 1 | 1 | 0 | 0 | 1 | 10 | 52 | 95 | 107 | 44 |
| Total assets | 9 | 40 | 47 | 28 | 27 | 15 | 98 | 241 | 226 | 154 | 163 |
| Accounts payable | 1 | 1 | 3 | 1 | 1 | 3 | 5 | 13 | 8 | 4 | 5 |
| Long-term debt, current | - | - | - | - | - | - | - | - | - | 2 | 3 |
| Total current liabilities | 2 | 3 | 7 | 2 | 2 | 5 | 10 | 22 | 18 | 19 | 18 |
| Long-term debt, non-current | - | - | - | - | - | - | - | - | - | 7 | 5 |
| Total non-current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 30 | 5 |
| Total liabilities | 2 | 3 | 7 | 2 | 2 | 5 | 11 | 22 | 19 | 49 | 23 |
| Common stock and paid-in capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained earnings | - | -54 | -102 | -141 | -162 | -217 | -268 | -360 | -470 | -601 | -731 |
| Stockholders' equity | 7 | 36 | 40 | 25 | 25 | 9 | 88 | 219 | 207 | 106 | 140 |
| Total debt | - | - | - | - | - | - | - | - | - | 9 | 7 |
| Net debt | - | - | - | - | - | - | - | - | - | -17 | -92 |
| D/E ratio (%) | - | - | - | - | - | - | - | - | - | 8.4 | 5.4 |
| Working capital | - | - | - | - | - | - | - | - | - | - |